European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 2 , Pages 155-168 , August 2006

Comparison of Carbon-impregnated and Standard ePTFE Prostheses in Extra-anatomical Anterior Tibial Artery Bypass: A Prospective Randomized Multicenter Study

  • X. Kapfer

      Affiliations

    • Department of Thoracic and Vascular Surgery, University Hospital Ulm, Ulm, Germany
    • ,
  • W. Meichelboeck

      Affiliations

    • Birkenallee 58, 82349 Pentenried, Germany
    • Corresponding Author InformationCorresponding author. W. Meichelboeck, Dipl.-Ing., Birkenallee 58, 82349 Pentenried, Germany.
    • ,
  • F.-M. Groegler

      Affiliations

    • Department of Vascular and Thoracic Surgery, Oberschwaben Klinik gGmbH, Ravensburg, Germany

,Accepted 17 December 2005.

References 

  1. Hall RG, Coupland GA, Lane R, Delbridge L, Appleberg M. Vein, gore-tex or a composite graft for femoropopliteal bypass. Surg Gynecol Obstet. 1985;161(4):308–312
  2. Cheshire NJ, Wolfe JH, Noone MA, Davies L, Drummond M. The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein. J Vasc Surg. 1992;15(1):167–174
  3. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures. J Vasc Surg. 1993;18(5):867–874
  4. Parsons RE, Suggs WD, Veith FJ, Sanchez LA, Lyon RT, Marin ML, et al. Polytetrafluoroethylene bypasses to infrapopliteal arteries without cuffs or patches: a better option than amputation in patients without autologous vein. J Vasc Surg. 1996;23(2):347–354
  5. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3(1):104–114
  6. Veterans Administration Cooperative Study Group. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization. Veterans Administration Cooperative Study Group. Arch Surg. 1988;123(4):434–438
  7. Londrey GL, Ramsey DE, Hodgson KJ, Barkmeier LD, Sumner DS. Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg. 1991;13(5):631–636
  8. Gott VL, Koepke DE, Daggett RL, Zarnstorff W, Young WP. The coating of intravascular plastic prostheses with colloidal graphite. Surgery. 1961;50:382–389
  9. Gott VL, Daggett RL, Koepke DE, Rowe GG, Young WP. Replacement of the canine pulmonary valve and pulmonary artery with a graphite-coated valve prosthesis. J Thorac Cardiovasc Surg. 1962;44:713–723
  10. Gott VL, Whiffen JD, Dutton RC. Heparin bonding on colloidal graphite surfaces. Science. 1963;142:1297–1298
  11. Sharp WV, Gardner DL, Andresen GJ. A bioelectric polyurethane elastomere for intravascular replacement. Trans Am Soc Artif Intern Organs. 1966;12:179–182
  12. Sharp WV. Bioelectric properties of the vascular system as related to artificial internal organs. Surgery. 1967;61(5):763–767
  13. Sharp WV, Gardner DL, Andresen GJ, Wright J. Electrolour: a new vascular interface. Trans Am Soc Artif Intern Organs. 1968;14:73–77
  14. Adams D, Williams DF, Hill J. Carbon fiber-reinforced carbon as a potential implant material. J Biomed Mater Res. 1978;12(1):35–42
  15. Olcott EL. Pyrolytic biocarbon materials. J Biomed Mater Res. 1974;8(3):209–217
  16. Miller BG, Dyer KA, Taylor BC, Wright JI, Sharp WV. Electrical conductivity: effect on intravascular performance of foams, velour, flock, and fabric. Trans Am Soc Artif Intern Organs. 1974;20A:91–100
  17. Taylor BC, Sharp WV, Wright JI, Ewing KL, Wilson CL. The importance of zeta potential, ultrastructure, and electrical conductivity to the in vivo performance of polyurethane-carbon black vascular prostheses. Trans Am Soc Artif Intern Organs. 1971;17:22–26
  18. Sharp WV, Teague PC. Pyrolytic carbon-coated grafts. In:  Dardik H editors. Graft materials in vascular surgery. Chicago: Year Book Medical Publishers; 1978;p. 203–212
  19. Haubold AD, Shim HS, Bokros JC. Carbon in medical devices. In:  Williams DF editors. Biocompatibility of clinical implant materials. vol. 2:Boca Raton, Florida: CRC Press Inc.; 1981;p. 3–42
  20. Homsy CA. Biocompatability of perfluoroninated polymers and composites of these polymers. In:  Williams DF editors. Biocompatibility of clinical implant materials. vol. 2:Boca Raton, Florida: CRC Press Inc.; 1981;p. 59–77
  21. Sharp WV. Update on carbon coated grafts. In:  Sawyer PN editors. Modern vascular grafts. New York: McGraw Hill; 1987;p. 215–224
  22. Goldfarb D, Houk JA, Moore JL, Gain DL. Graphite-expanded polytetrafluoroethylene: an improved small artery prosthesis. Trans Am Soc Artif Intern Organs. 1977;23:268–276
  23. Goldfarb D, Houk J, Moore J, Catron W. Modified graphite-expanded PTFE (G-PTFE) for use as a superior vena cava (SVC) substitute. Trans Am Soc Artif Intern Organs. 1978;24:201–208
  24. Debski R, Borovetz H, Haubold A, Hardesty R. Polytetrafluoroethylene grafts coated with ULTI carbon. Trans Am Soc Artif Intern Organs. 1982;28:456–458
  25. Debski R, Borovetz H, Haubold A, Hardesty R. ULTI carbon goretex: a new vascular graft. Curr Surg. 1983;40(3):198–200
  26. Kogel H, Cyba-Altunbay S, Pindur G, Seifried E, Ostermeyer U. Thrombogenicity of vascular prostheses in the short-term carotid artery test. A modified in vitro evaluation model. Vasa. 1988;17(3):177–185
  27. Tsuchida H, Cameron BL, Marcus CS, Wilson SE. Modified polytetrafluoroethylene: indium 111-labeled platelet deposition on carbon-lined and high-porosity polytetrafluoroethylene grafts. J Vasc Surg. 1992;16(4):643–649
  28. McHaney J, Banas C, inventors; IMPRA Inc.Tempe Ariz.USA, assignee. Carbon containing vascular graft and method of making it. US patent 5,827,327. 1998 Oct 27.
  29. Meichelboeck W. Is there a benefit of coating ePTFE vascular grafts with carbon?. In:  Chakfé N,  Durand B,  Kretz JG editor. ESVB 2003 new technologies in vascular biomaterials: polytetrafluoroethylene prostheses, impregnated vascular prostheses and surface treatment of vascular prostheses. Strasbourg, France: EUROPROT; 2003;p. 139–155[Chapter 15]
  30. Akers DL, Du YH, Kempczinski RF. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study. J Vasc Surg. 1993;18(1):10–15
  31. Babatasi G, Bara L, Galateau F, Agostini D, Massetti M, Gerard JL, et al. An animal model for the evaluation of graft thrombosis in the acute phase on carbon-lined PTFE prosthesis. Int J Artif Organs. 1994;17(12):643–650
  32. Ao PY, Hawthorne WJ, Vicaretti M, Fletcher JP. Development of intimal hyperplasia in six different vascular prostheses. Eur J Vasc Endovasc Surg. 2000;20(3):241–249
  33. Bacourt F, et l' A.U.R.C. Étude Prospective Randomisee Comparative de Protheses PTFE Carbone et PTFE Standard en Position Sous Articulaire. 1994 Jun 16; Annual Meeting of the French speaking Society of Vascular Surgery in Deauville; Jun 16–18 1994.
  34. Bacourt F. Prospective randomized study of carbon-impregnated polytetrafluoroethylene grafts for below-knee popliteal and distal bypass: results at 2 years. The Association Universitaire de Recherche en Chirurgie. Ann Vasc Surg. 1997;11(6):596–603
  35. Baste JC, Boissieras P, Midy D, Sassoust F, Martin F, Pheline P. Étude prospective comparative d'une prothese PTFE Carbone versus prothese standard dans les abords vasculaires pour hemodialyse chronique-resultas à un an. 1993 Jun 24; Hopital Saint André, Bordeaux, France. 8th meeting of the French Society of Vascular Surgery, Paris; June 24 1993.
  36. Bourquelot P, Stolba J, Cheret P, Fournier F, Mouton A. Carbon-PTFE versus Standard-PTFE AV-Bridge grafts for chronic hemodialysis. In:  Henry ML,  Ferguson RM editor. Vascular Access for Hemodialysis—IV. W.L. Gore and Ass. Inc. Precept Press; 1995;p. 303–307
  37. Stockmann U. [Extra-anatomic crural reconstruction. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989;613–615
  38. Stockmann U, Albiker C. [Peripheral prosthesis bypass for saving the extremity]. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:544–546
  39. Batson RC, Sottiurai VS, Craighead CC. Linton patch angioplasty. An adjunct to distal bypass with polytetrafluoroethylene grafts. Ann Surg. 1984;199(6):684–693
  40. Miller JH, Foreman RK, Ferguson L, Faris I. Interposition vein cuff for anastomosis of prosthesis to small artery. Aust N Z J Surg. 1984;54(3):283–285
  41. Taylor RS, Loh A, McFarland RJ, Cox M, Chester JF. Improved technique for polytetrafluoroethylene bypass grafting: long-term results using anastomotic vein patches. Br J Surg. 1992;79(4):348–354
  42. Wolfe JH. Polytetrafluoroethylene (PTFE) femorodistal bypass. In: Jamieson CW, Yao JST, editors. Rob & Smith Operative Surghery - Vascular Surgery. 5th. 1994;330–340
  43. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ. 2002;325(7365):652–654
  44. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–538
  45. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–694
  46. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134(8):657–662
  47. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101(1):E16–E22
  48. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136(12):873–883
  49. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18(2):185–192
  50. Taylor LM, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg. 1990;11(2):193–205
  51. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg. 1997;26(4):543–550
  52. Stonebridge PA, Naidu S, Colgan MP, Moore DJ, Shanik DG, McCollum PT. Tibial and peroneal artery bypasses using polytetrafluoroethylene (PTFE) with an interposition vein cuff. J R Coll Surg Edinb. 2000;45(1):17–20
  53. Meichelboeck W. [Do we need a new morphological analysis method for the ‘run-off’? An analysis of more than 700 patients with distal bypass.] Brauchen wir eine neue morphologische Bewertungsmethode des ‘Run-Off’? Eine Analyse von mehr als 700 Patienten mit distalem Bypass. 18th Annual Meeting of the German Society of Vascular and Endovascular Surgery, Sept. 11–14, Würzburg Germany. 2002;p. 139
  54. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Karmody A, Baker JD, et al. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1986;4(1):80–94
  55. Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CA. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg. 2003;37(6):1263–1269
  56. Fichelle JM, Marzelle J, Colacchio G, Gigou F, Cormier F, Cormier JM. Infrapopliteal polytetrafluoroethylene and composite bypass: factors influencing patency. Ann Vasc Surg. 1995;9(2):187–196
  57. Ascher E, Scheinman M, Mazzariol F, Kallakuri S, Hingorani A. Comparison between supra- and infrainguinal inflow sites for infrapopliteal PTFE bypasses with complementary arteriovenous fistula and vein interposition. Eur J Vasc Endovasc Surg. 2000;19(2):138–142
  58. Kreienberg PB, Darling RC, Chang BB, Paty PS, Lloyd WE, Shah DM. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs. J Vasc Surg. 2000;31(4):696–701
  59. Ruckert RI, Settmacher U, Kruger U, Scholz H. Femorodistal PTFE bypass grafting for severe limb ischaemia: results of a prospective clinical study using a new distal anastomotic technique. Eur J Vasc Endovasc Surg. 2000;20(1):51–56
  60. Lang W, Hatzl J, Hennig G, Teßarek J, Balzer K, Zehle A, et al. Femoro-poplitealer P3-Bypass mit Carbon oder Standard PTFE: Kann man Unterschiede entdecken? Eine propektiv randomisierte Multicenterstudie.. Joint Meeting of the Societies of Vascular and Endovascular Surgery Germany, Switzerland and Austria, Sept. 19-22, Hamburg Germany. 2001;
  61. Lang W. Publication of study results: ‘Carbon vs. Standard PTFE in below knee popliteal bypass’. 2004. Ref Type: Personal Communication.
  62. Haase J, Storger H, Hofmann M, Schwarz CE, Reinemer H, Schwarz F. Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions. J Invasive Cardiol. 2003;15(10):562–565
  63. Airoldi F, Colombo A, Tavano D, Stankovic G, Klugmann S, Paolillo V, et al. Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease. Am J Cardiol. 2004;93(4):474–477
  64. Zeller T, Rastan A, Kliem M, Schwarzwalder U, Frank U, Burgelin K, et al. Impact of carbon coating on the restenosis rate after stenting of atherosclerotic renal artery stenosis. J Endovasc Ther. 2005;12(5):605–611
  65. De SI, Szilard M, Yanming H, Ping XB, Verbeken E, Neerinck D, et al. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model. J Invasive Cardiol. 2000;12(8):389–394
  66. Gutensohn K, Beythien C, Bau J, Fenner T, Grewe P, Koester R, et al. In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res. 2000;99(6):577–585
  67. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Bolognese L, et al. Clinical and angiographic outcomes following elective implantation of the carbostent in patients at high risk of restenosis and target vessel failure. Catheter Cardiovasc Interv. 2001;54(4):420–426
  68. Linder S, Pinkowski W, Aepfelbacher M. Adhesion, cytoskeletal architecture and activation status of primary human macrophages on a diamond-like carbon coated surface. Biomaterials. 2002;23(3):767–773
  69. Galloni M, Prunotto M, Santarelli A, Laborde F, Dibie A, Isaia C, et al. Carbon-coated stents implanted in porcine iliac and renal arteries: histologic and histomorphometric study. J Vasc Interv Radiol. 2003;14(8):1053–1061

PII: S1078-5884(06)00008-6

doi: 10.1016/j.ejvs.2005.12.015

European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 2 , Pages 155-168 , August 2006

Article Tools

* Image Usage & Resolution